Adherence to prescribed oral hypoglycaemic medication in a population of patients with Type 2 diabetes: a retrospective cohort study
- 9 April 2002
- journal article
- research article
- Published by Wiley in Diabetic Medicine
- Vol. 19 (4), 279-284
- https://doi.org/10.1046/j.1464-5491.2002.00689.x
Abstract
Aims To evaluate the patterns and predictors of adherence in all patients with Type 2 diabetes in the community receiving treatment with a single oral hypoglycaemic drug. In particular, to test the hypothesis that one tablet per day is associated with better adherence than more than one. Methods The study design was a retrospective cohort study set in the Tayside region of Scotland (population approx. 400 000). Participants were residents of Tayside from 1 January 1993 until 31 December 1995 with at least 12 months of prescriptions of oral hypoglycaemic drugs (OHDs). The main outcome measures were adherence indices for sulphonylureas and metformin separately, adjusting for prescribing while hospitalized. Results Of the total 2920 subjects identified, adequate adherence (≥ 90%) was found in 31% of those prescribed sulphonylureas alone (n = 1329, median adherence = 300 days per year), and in 34% of those prescribed metformin alone (n = 528, median = 302 days per year). There were significant linear trends of poorer adherence with each increase in the daily number of tablets taken (p = 0.001) and increase in co‐medication (p = 0.0001) for sulphonylureas alone after adjustment for other factors. Conclusions In the community only one in three with Type 2 diabetes had adequate adherence to OHDs. One tablet per day administration was associated with greater adherence than multiple tablets. Poor adherence is a major obstacle to the benefit of complex drug regimens in the treatment of Type 2 diabetes.Keywords
This publication has 18 references indexed in Scilit:
- Frequency of blood glucose monitoring in relation to glycaemic control: observational study with diabetes databaseBMJ, 1999
- Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)The Lancet, 1998
- Beta-cell deterioration determines the onset and rate of progression of secondary dietary failure in Type 2 diabetes mellitus: the 10-year follow-up of the Belfast Diet StudyDiabetic Medicine, 1998
- Adherence to insulin treatment, glycaemic control, and ketoacidosis in insulin-dependent diabetes mellitusThe Lancet, 1997
- Impact of Dosage Frequency on Patient ComplianceDiabetes Care, 1997
- The diabetes audit and research in Tayside Scotland (darts) study: electronic record linkage to create a diabetes registerBMJ, 1997
- Microelectronic Systems for Monitoring and Enhancing Patient Compliance With Medication RegimensDrugs, 1995
- Age as a Major Factor Affecting Adherence to Medication for Hypertension in a General Practice PopulationFamily Practice, 1988
- Use of a pharmacologic indicator to compare compliance with tablets prescribed to be taken once, twice, or three times dailyClinical Pharmacology & Therapeutics, 1988
- Elders' Nonadherence, Its Assessment, and Computer Assisted Instruction for Medication Recall TrainingJournal of the American Geriatrics Society, 1988